{
}
Argus has issued "buy" ratings for several pharmaceutical stocks, including Sanofi (SNY) with a $60 price target, Gilead Sciences (GILD) at $85, and GSK at $45. The sector is projected to grow significantly, driven by oncology sales, with companies like Johnson & Johnson and Merck also highlighted for their strong pipelines and dividend yields.
Jasper Hellweg
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pharmaceutical stocks to consider for income and growth potential
Johnson & Johnson
Merck & Co., Inc.
Perrigo Company plc
GSK plc
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
FRA
USA
Jasper Hellweg
Kristina Ruggeri
David Toung
Show more
20:44 15.10.2024
Trending
Subcategory
Corporate News
AI Innovations
Industry Trends
Startups & Entrepreneurship
Emerging Startups
Funding Rounds & Investments
Fintech Startups
Venture Capital Investments
Economic Indicators
Private Equity Deals
Cryptocurrency Trends
Retail and Consumer Goods
Cybersecurity Innovations & Tech
Product Launches
Global Trade Developments
Stock Market Updates
AI Applications
Market Analysis and Predictions
Industry Mergers & Acquisitions
Crypto Adoption and Integration
Countries:
Companies:
Huawei Technologies CO. Ltd.
NVIDIA Corporation
Nvidia Corporation
Apple Inc.
Google Inc.
Microsoft Corporation
XPeng Inc.
SWIGGY LIMITED
Vecmocon Technologies Ltd.
Emaar Properties PJSC
Deyaar Development PJSC
Maverick Ventures (Israel) 1.5 GP Ltd.
SuperSeed B.V.
Microsoft Corporation Corp.
Toyota Motor Corporation
Berner Kantonalbank AG
Amazon.com Inc.
Medius Holdings Co., Ltd.
SITC International Holdings Company Limited
Firefly AB (publ)
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Swiss Franc
British Pound Sterling
Japanese Yen
South African Rand
Filipino Peso
Norwegian Krone
Offshore Chinese Yuan
People: